U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
129451129451Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle SprainCompletedNo Results AvailableAcute Pain|Ankle SprainDrug: Diclofenac Sodium|Drug: Matching Placebo Patchhttps://ClinicalTrials.gov/show/NCT00869180
129452129452Ramelteon for Insomnia Comorbid With AsthmaTerminatedHas ResultsInsomnia|AsthmaDrug: Ramelteonhttps://ClinicalTrials.gov/show/NCT00869167
129453129453Multidisciplinary Treatment in Patients With Mild Traumatic Brain InjuryActive, not recruitingNo Results AvailableTraumatic Brain Injury With Brief Loss of ConsciousnessBehavioral: primary care follow up|Behavioral: Multidisciplinary follow uphttps://ClinicalTrials.gov/show/NCT00869154
129454129454Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for GlaucomaCompletedHas ResultsGlaucomaDrug: glaucoma medications (Timolol, Brimonidine, Dorzolamide, Brinzolamide)https://ClinicalTrials.gov/show/NCT00869141
129455129455A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From InsomniaCompletedHas ResultsDiabetes Mellitus, Type 2|InsomniaDrug: Circadin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00869128
129456129456Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart FailureWithdrawnNo Results AvailableHeart FailureDrug: Istaroxime|Drug: Istaroxime|Drug: Istaroxime|Drug: Istaroximehttps://ClinicalTrials.gov/show/NCT00869115
129457129457Characterization of Beta Cell FailureWithdrawnNo Results AvailableDiabetes|Metabolic SyndromeDrug: GLP-1https://ClinicalTrials.gov/show/NCT00869102
129458129458Safety and Efficacy of CC-10004 for Prurigo NodularisCompletedHas ResultsPrurigo NodularisDrug: CC-10004https://ClinicalTrials.gov/show/NCT00869089
129459129459Pharmacists Management of DiabetesCompletedNo Results AvailableDiabetes MellitusOther: Pharmacist Management|Other: Usual carehttps://ClinicalTrials.gov/show/NCT00869076
129460129460Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or ContusionCompletedNo Results AvailableAcute PainDrug: Diclofenac Sodium Patch|Drug: Matching Placebo Patchhttps://ClinicalTrials.gov/show/NCT00869063
129461129461Capecitabine and Temozolomide for Neuroendocrine CancersCompletedNo Results AvailableNeuroendocrine TumorsDrug: Capecitabine|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00869050
129462129462Analgesia After Total Knee ArthroplastyRecruitingNo Results AvailableAnalgesiaDrug: Periarticular Injection|Drug: CFNB + Posterior Capsular Injectionhttps://ClinicalTrials.gov/show/NCT00869037
129463129463Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device PlacementActive, not recruitingNo Results AvailableHeart FailureBiological: Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cellshttps://ClinicalTrials.gov/show/NCT00869024
129464129464Exercise for Patients With Renal Cell Cancer Receiving SunitinibRecruitingNo Results AvailableRenal Cell CarcinomaOther: Endurance exercisehttps://ClinicalTrials.gov/show/NCT00869011
129465129465GTX Regimen for Biliary CancersTerminatedNo Results AvailableBiliary CancerDrug: Gemcitabine, docetaxel, and capecitabinehttps://ClinicalTrials.gov/show/NCT00868998
129466129466Effects of Oral PEG 3350 on Electrolyte BalanceCompletedNo Results AvailableChronic ConstipationDrug: PEG 3350 plus electrolytes|Drug: PEG 3350 without electrolyteshttps://ClinicalTrials.gov/show/NCT00868985
129467129467Renal Stenting With Distal Atheroembolic ProtectionRecruitingNo Results AvailableRenal Artery Obstruction|Renovascular HypertensionProcedure: Percutaneous renal stenting intervention|Device: Distal embolic protectionhttps://ClinicalTrials.gov/show/NCT00868972
129468129468Lurasidone - A 24-week Extension Study of Patients With Bipolar I DepressionCompletedHas ResultsBipolar DepressionDrug: lurasidonehttps://ClinicalTrials.gov/show/NCT00868959
129469129469Ribavirin for Hemorrhagic Fever With Renal Syndrome in GermanyEnrolling by invitationNo Results AvailableHemorrhagic Fever With Renal SyndromeDrug: Virazole (Ribavirin)https://ClinicalTrials.gov/show/NCT00868946
129470129470Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver DiseaseCompletedNo Results AvailableNonalcoholic Fatty Liver DiseaseOther: Low glycemic index dietary intervention program|Other: simple lifestyle advicehttps://ClinicalTrials.gov/show/NCT00868933
129471129471Patient-Controlled Sedation Versus Anesthesiologist-Administered SedationCompletedNo Results AvailableColonoscopyOther: patient control of pump|Other: anesthesiologist controlled sedationhttps://ClinicalTrials.gov/show/NCT00868920
129472129472Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With FoodCompletedNo Results AvailableHealthyDrug: 35 mg risedronate DR tablet|Drug: 35 mg risedronate DR tablet|Drug: 35 mg risedronate DR tablethttps://ClinicalTrials.gov/show/NCT00868907
129473129473Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: DE-104 medium concentration|Drug: DE-104 high concentration|Drug: Placebo|Drug: 0.005% latanoprosthttps://ClinicalTrials.gov/show/NCT00868894
129474129474Treatment of Hypertension in Primary Care in SpainCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT00868881
129475129475Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal TherapyRecruitingNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT00868868
129476129476Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-Critical Coronary Artery DiseaseEnrolling by invitationNo Results AvailableCoronary Artery DiseaseDrug: Bradykininhttps://ClinicalTrials.gov/show/NCT00868855
129477129477Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing AnaphylaxisCompletedNo Results AvailableAnaphylaxishttps://ClinicalTrials.gov/show/NCT00868842
129478129478Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry TrialRecruitingNo Results AvailableCoronary Heart DiseaseDevice: Firebird2https://ClinicalTrials.gov/show/NCT00868829
129479129479Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 CyclesCompletedNo Results AvailableColorectal CancerDrug: 12 cycles of oxaliplatine based adjuvant chemotherapy|Drug: 8 cycles of oxaliplatine based adjuvant chemotherapyhttps://ClinicalTrials.gov/show/NCT00868816
129480129480Aberrant Gene Expression Prostate CarcinomaActive, not recruitingNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT00868803

* Görseller ve İçerik tekif hakkına sahip olabilir